MARSHALL WACE, LLP - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$22,309,000
+1296.1%
296,462
+2160.5%
0.05%
+411.1%
Q4 2020$1,598,000
+40.2%
13,115
+0.5%
0.01%
+28.6%
Q3 2020$1,140,000
+35.2%
13,0520.0%0.01%
+16.7%
Q2 2020$843,000
+360.7%
13,052
+218.4%
0.01%
+200.0%
Q1 2020$183,0004,0990.00%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q1 2021.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders